| ²é¿´: 380 | »Ø¸´: 1 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
yin198716гæ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇóÖú·Òë
|
|
| Clinical resistance to anti-VEGF therapy highlights the need for targeting additional tumor angiogenesis signaling pathways. |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸ ½ÄÏ´óѧ 085602 »¯¹¤×¨Ë¶ 338·ÖÇóµ÷¼Á
ÒѾÓÐ14È˻ظ´
312Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸ºÓ±±¹¤Òµ´óѧ²ÄÁϹ¤³Ì£¬³õÊÔ344Çóר˶µ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏר˶322
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
0703»¯Ñ§
ÒѾÓÐ14È˻ظ´
µ÷¼Á Ò»Ö¾Ô¸¼ªÁÖ´óѧ357·Ö
ÒѾÓÐ3È˻ظ´
»¯Ñ§µ÷¼Á
ÒѾÓÐ18È˻ظ´

º£±ßµÄÌì
гæ (СÓÐÃûÆø)
- ·ÒëEPI: 6
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 90.9
- É¢½ð: 100
- ºì»¨: 1
- Ìû×Ó: 87
- ÔÚÏß: 59.7Сʱ
- ³æºÅ: 2507861
- ×¢²á: 2013-06-14
2Â¥2013-06-24 13:23:30














»Ø¸´´ËÂ¥